Skip to main content
Get Alerts

Data Explorer

Research historical outbreak investigations and the full recall archive, with charts, trends, and advanced filters. Looking for what's happening right now instead? See current Health Alerts.

Recall totals

All FDA and USDA recalls in Public Health Trace, June 2012 to October 2026.

37,240
Total recall recordsAll FDA and USDA recalls in Public Health Trace
9,844
Class I recallsReasonable probability of serious health consequences
24,383
Class II recallsTemporary or medically reversible health consequences
2,897
Class III recallsNot likely to cause adverse health consequences

Quick insights

A snapshot of the most notable patterns across all recorded FDA and USDA recalls.

Most recalled product100 vegetarian Fenugreek Capsules 90 count, 600mg, packaged in 150cc Amber Glass Packer with White Polypropylene Cap. 53 recalls
Most common hazardLack of Assurance of Sterility 2,084 recalls
Newest recallhttp://www.fda.gov/safety/recalls-market-withdrawals-safety-alerts/gardeners-basics-recalls-waltham-29-broccoli-sprouting-seeds-due-possible-salmonella-contaminationPublished October 8, 2026
Most affected stateHawaii 200 recalls mention this state

Download matching recalls as CSV

CSV exports include up to 5,000 matching rows (applying your current filters), not the full dataset if it's larger.

Filters
Recall details
Location
Date range
Sort results
Clear filters
Metric
View
Recalls announced by month (Year to date)

A chart of recalls grouped by month.

Download CSV

Source: FDA and USDA public dataLast updated

Summary (Year to date)

  • 1,739 recalls have been announced year to date.
  • Sep 2026 was 15% higher than the previous complete period (Aug 2026: 182).
  • The highest complete period was Jun 2026 (300).
  • Oct 2026 is incomplete and not included in the figures above.
  • Complete data
  • Incomplete
Recalls by class

A bar chart of the total number of recalls in this dataset by recall class.

Recalls by class
ClassRecalls
Class II24,383
Class I9,844
Class III2,897
Not Yet Classified2
Download CSV
Recalls by class
ClassRecalls
Class II24,383
Class I9,844
Class III2,897
Not Yet Classified2

Showing 18,161–18,180 of 21,658 recalls

FDA Recall TerminatedTerminated: November 18, 2020Historical recordClass III

Bravelle 75 IU (urofollitropin for injection, purified) For Subcutaneous or Intramuscular Injection Only, 1 Carton (contains 5 single dose vials of Bravelle, 5 single dose vials of 0.9% Sodium Chloride Inj., USP, 2 mL, and 5 Q-Cap Vial Adaptors) , Rx Only, Manufactured for: Ferring Pharmaceuticals, Inc. Parsippany, NJ 07054, By: Ferring Gmbh, Kiel Germany, NDC 55566-8505-6

by Ferring Pharmaceuticals Inc

Reason
Subpotent Drug
Published
October 21, 2015
Distribution
Nationwide

View recall →

FDA Recall TerminatedTerminated: April 10, 2017Historical recordClass II

Metformin Hydrochloride Extended-Release Tablets, 1000 mg, 60-count bottle, Rx only, Manufactured by: Actavis Laboratories FL, Inc., Fort Lauderdale, FL 33314 USA; Distributed by: Actavis Pharma, Inc., Parsippany, NJ 07054 USA; NDC 0591-2720-60; UPC 3 05912 72060 3.

by Actavis Laboratories, FL, Inc.

Reason
Failed Dissolution Specifications: Low Out-of-Specification results for the 8 hour timepoint.
Published
October 21, 2015
Distribution
Nationwide

View recall →

FDA Recall TerminatedTerminated: August 2, 2016Historical recordClass II

Sedalmex (Acetaminophen 500 mg with Caffeine 65 mg) Pain Reliever tablets, 20-count tablets in blisters per box, Manufactured in Mexico by: Merck, S.A. de C.V./, Imported & Distributed by Midway Importing, Inc., 1807 Brittmoore Rd, Houston, TX 77043, UPC: 1 88436 00017 4.

by Midway Importing, Inc

Reason
Cross Contamination With Other Products: Potential cross-contamination of cephalosporin.
Published
October 21, 2015
Distribution
Nationwide

View recall →

FDA Recall TerminatedTerminated: February 19, 2016Historical recordClass III

FUROSEMIDE Tablets USP, 40 mg, 1000-count bottle, Rx only, Boehringer Ingelheim Roxane Laboratories, Roxane Laboratories, Inc., Columbus, OH 43216, NDC 0054-4299-31, UPC 3 0054-4299-31 2.

by Boehringer Ingelheim Roxane Inc

Reason
CGMP Deviations: The active pharmaceutical ingredient (API) intended for use in furosemide oral solution USP was inadvertently used to manufacture the recalled furosemide tablets USP.
Published
October 21, 2015
Distribution
Nationwide

View recall →

FDA Recall TerminatedTerminated: February 19, 2016Historical recordClass III

FUROSEMIDE Tablets USP, 20 mg, 1000-count bottle, Rx only, Boehringer Ingelheim Roxane Laboratories, Roxane Laboratories, Inc., Columbus, OH 43216, NDC 0054-4297-31, UPC 3 0054-4297-31 8.

by Boehringer Ingelheim Roxane Inc

Reason
CGMP Deviations: The active pharmaceutical ingredient (API) intended for use in furosemide oral solution USP was inadvertently used to manufacture the recalled furosemide tablets USP.
Published
October 21, 2015
Distribution
Nationwide

View recall →

FDA Recall TerminatedTerminated: February 10, 2017Historical recordClass II

Ipratropium Bromide 0.5 mg and Albuterol Sulfate 3 mg Inhalation Solution, packaged in 30x3 mL Sterile Unit-Dose Vials, a) 30 count (NDC 0487-0201-03) and b) 60 count (NDC 0487-0201-60) vials per carton, Rx only, Nephron Pharmaceutical Corporation, Orlando, FL

by Nephron Pharmaceuticals Corp.

Reason
Lack of Assurance of Sterility; potential exposure to non-sterile lubricant during the filling process
Published
October 21, 2015
Distribution
Nationwide

View recall →

FDA Recall TerminatedTerminated: June 15, 2022Historical recordClass II

Bromfenac Ophthalmic Solution 0.09%, packaged in a) 1.7 mL bottle (NDC 60505-0595-05), b) 2.5 mL bottle (NDC 60505-0596-04), Rx Only, Mfg for: Apotex Corp., Weston, FL 33326.

by Apotex Inc.

Reason
Lack of Assurance of Sterility: Failed preservative effectiveness testing
Published
October 21, 2015
Distribution
Nationwide

View recall →

FDA Recall TerminatedTerminated: March 20, 2019Historical recordClass II

Daytrana (methylphenidate transdermal system), 30 mg over 9 Hour Patches (3.3 mg/hr), 30 Ct Carton, Rx Only, Manufactured for: Noven Therapies, LLC., Miami, FL 33186, by: Noven Pharmaceuticals, Inc., Miami, FL 33186. NDC: 68968-5555-3

by Noven Pharmaceuticals, Inc.

Reason
Defective Delivery System: Out of specification for z-statistic related to mechanical peel force.
Published
October 14, 2015
Distribution
Nationwide

View recall →

FDA Recall TerminatedTerminated: May 4, 2016Historical recordClass II

Vytorin (ezetimibe and simvastatin) tablets, 10 mg/20 mg, each tablet contains 10 mg ezetimibe and 20 mg simvastatin, Rx Only, 1000 count Bottle, Manuf. For Merck Sharp & Dohme Corp, a subsidiary of Merck & Co., Inc., Whitehouse Station, NJ 08889, NDC 66582-0312-82.

by Merck Sharp & Dohme, Wilson Facility

Reason
Presence of Foreign Tablet/Capsule: Vytorin 10 mg/40 mg tablets were found in bottles of Vytorin 10 mg/20 mg tablets.
Published
October 14, 2015
Distribution
KY, MS and OH.

View recall →

FDA Recall TerminatedTerminated: January 12, 2016Historical recordClass II

Sermorelin 6mg/6mL Lyophilized Powder, Sterile Compound for Subcutaneous Injection, Diabetes Corporation of America dba DCA Pharmacy, Franklin, TN 37064-5527

by Diabetes Corporation of America dba DCA Pharmacy

Reason
Lack of Assurance of Sterility: A recent FDA inspection found that this product was not being compounded in an area appropriate for lyophilization which may lead to a lack of sterility assurance.
Published
October 14, 2015
Distribution
Multiple states

View recall →

FDA Recall TerminatedTerminated: February 15, 2017Historical recordClass III

Verapamil Hydrochloride Extended-Release tablets, USP, 240 mg, 500-count bottles, Rx Only, Apotex Corp. Manufactured by Apotex Research Private Limited, Bangalore, Karnataka 560 099, India; Manufactured for: Apotex Corp., Weston, FL 33326. NDC 60505-2742-5.

by Apotex Inc.

Reason
Failed Dissolution Specification: One lot of product did not meet the first stage dissolution specification limits.
Published
October 7, 2015
Distribution
Nationwide

View recall →

FDA Recall TerminatedTerminated: August 30, 2016Historical recordClass II

All Products Intended to be Sterile, mediStat Pharmacy, 110 East Azalea Ave., Foley, AL 36535, 844*737*2550. An Incomplete List of Recalled Products Includes 1) All Cyanacobalamin Products, 2) All Magnesium Chloride Products, 3) All Lipostat (MIC B12) Products, 4) All Trimix (Papaverine/ Aloprostadil/ Phentolamine) Products, 5) All Testosterone Products, 6) All Dexamethasone Products, 7) All Levocarnitine Products, 8) All Hydroxyprogesterone Caproate Products, 9) All Triamcinolone Products, 10) All Betamethasone Sodium Phosphate Products, 11) All Methylprednisolone Acetate Products.

by Medistat RX L.L.C.

Reason
Lack of Assurance of Sterility
Published
October 7, 2015
Distribution
Nationwide

View recall →

FDA Recall TerminatedTerminated: February 14, 2017Historical recordClass III

METOCLOPRAMIDE ORAL SOLUTION, USP 10 mg/10 mL, 10 mL cups, Rx only. Manufactured by VistaPharm, Inc, Largo, FL. NDC: 66689-031-01.

by VistaPharm, Inc.

Reason
Defective Container: Lids on unit dose cups are not fully qualified.
Published
October 7, 2015
Distribution
U.S. Including: CA, IL, LA, OH, PA, and…

View recall →

FDA Recall TerminatedTerminated: October 2, 2015Historical recordClass III

Rodan & Fields Proactiv Solution, Sheer Finish Compact Foundation, salicylic acid acne treatment, DARK, 7 g/0.25 OZ. Compacts, Over the Counter. Manufactured for Guthy-Renker Palm Desert, CA 92250.

by Guthy-Renker LLC

Reason
Subpotent Drug: Salicylic acid is subpotent.
Published
October 7, 2015
Distribution
Nationwide

View recall →

FDA Recall TerminatedTerminated: October 2, 2015Historical recordClass III

Rodan & Fields Proactiv Solution, Sheer Finish Compact Foundation, salicylic acid acne treatment, TAN, 7 g/0.25 OZ. Compacts, Over the Counter. Manufactured for Guthy-Renker Palm Desert, CA 92250.

by Guthy-Renker LLC

Reason
Subpotent Drug: Salicylic acid is subpotent.
Published
October 7, 2015
Distribution
Nationwide

View recall →

FDA Recall TerminatedTerminated: October 2, 2015Historical recordClass III

Rodan & Fields Proactiv Solution, Sheer Finish Compact Foundation, salicylic acid acne treatment, MEDIUM, 7 g/0.25 OZ. Compacts, Over the Counter. Manufactured for Guthy-Renker Palm Desert, CA 92250.

by Guthy-Renker LLC

Reason
Subpotent Drug: Salicylic acid is subpotent.
Published
October 7, 2015
Distribution
Nationwide

View recall →

FDA Recall TerminatedTerminated: October 2, 2015Historical recordClass III

Rodan & Fields Proactiv Solution, Sheer Finish Compact Foundation, salicylic acid acne treatment, LIGHT, 7 g/0.25 OZ. Compacts, Over the Counter. Manufactured for Guthy-Renker Palm Desert, CA 92250.

by Guthy-Renker LLC

Reason
Subpotent Drug: Salicylic acid is subpotent.
Published
October 7, 2015
Distribution
Nationwide

View recall →

FDA Recall TerminatedTerminated: October 2, 2015Historical recordClass III

Rodan & Fields Proactiv Solution, Sheer Finish Compact Foundation, salicylic acid acne treatment, FAIR, 7 g/0.25 OZ. Compacts, Over the Counter. Manufactured for Guthy-Renker Palm Desert, CA 92250.

by Guthy-Renker LLC

Reason
Subpotent Drug: Salicylic acid is subpotent.
Published
October 7, 2015
Distribution
Nationwide

View recall →

FDA Recall TerminatedTerminated: January 27, 2017Historical recordClass I

PHENYLephrine HCl, 10 mg added to 250 mL 0.9% Sodium Chloride Injection USP (40 mcg per mL), packaged in 250 ml bags, Rx only, PharMEDium Services, LLC, 12620 W. Airport Blvd., Sugar Land, TX 77478, NDC# 61553-149-50

by PharMEDium Services, LLC

Reason
Presence of Particulate Matter: The firm manufactured products using Hospira 0.9% Sodium Chloride, USP injection which were subsequently recalled due to the presence of particulate matter (human hair).
Published
September 30, 2015
Distribution
Nationwide

View recall →

FDA Recall TerminatedTerminated: January 27, 2017Historical recordClass I

PHENYLephrine HCl, 60 mg added to 250 mL 0.9% Sodium Chloride Injection USP (240 mcg per mL), packaged in 250 ml bags, Rx only, PharMEDium Services, LLC, 12620 W. Airport Blvd., Sugar Land, TX 77478, NDC# 61553-236-50

by PharMEDium Services, LLC

Reason
Presence of Particulate Matter: The firm manufactured products using Hospira 0.9% Sodium Chloride, USP injection which were subsequently recalled due to the presence of particulate matter (human hair).
Published
September 30, 2015
Distribution
Nationwide

View recall →

Data last updated:

Recall records are summarized from official FDA and USDA sources. Notices may be updated, reclassified, terminated, or withdrawn. Always review the linked official notice for the most current instructions. Read the full medical disclaimer.